AllerGen NCE Inc.
AllerGen's Research Showcase
AllerGen's Fifth Annual Research Conference Program in English and French
February 7-9, 2010, Chateau Frontenac, Quebec City.
Register online or fill out and send the registration form
Response to Chatelaine
NEW! AllerGen's letter of support to Anaphylaxis Canada in response to recent Chatelaine article 'It's just Nuts' .
AllerGen awards $11 million in research funds
AllerGen recently awarded $11 million to fund asthma and allergy research. These newly funded research projects will be supported to 2012 towards preventing, controlling or elimintating allergic and related immune diseases.
Lung Health Outcomes
AllerGen and CIHR have collaborated to investigate the link between the mucosal immune response in the lung and respiratory tract and disease outcomes.AllerGen Investigator Dr. Teresa To, Department Head, Population Health Sciences at Hospital for Sick Children, has received the Eminent Scientist of the Year 2008
Genapha Web Resource
The Genapha website allows for easy dissemination of research results and with the aid of graphical animations, the Genapha website engages the public in issues such as the genetics of asthma/allergy, genetic testing, and pharmacogenetics. Please visit http://genapha.icapture.ubc.ca/ for more information and try out the new software, please contact DDaley@mrl.ubc.ca if you have problems with the tools.
Newsletters NEW!
Winter editions of the internal and external newsletters Agenda and ReAction
Network Newsletter March 2009
Highly Qualified Personnel (HQP) newsletter Airways 2009
Fast Facts
AllerGen's fast facts have been updated.

